BIT Analytical Acquires C2 Diagnostics | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BIT Analytical Instruments has acquired French OEM diagnostics instruments firm C2 Diagnostics for an undisclosed sum.

Schwalbach, Germany-based BIT said that the deal will enable it to offer a larger range of services and technologies offered in the areas of clinical chemistry, immunology, and molecular diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.